✦ LIBER ✦

Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

✍ Scribed by J. Sun; J.-L. Hou; Q. Xie; X.-H. Li; J.-M. Zhang; Y.-M. Wang; H. Wang; J.-Y. Lai; S.-J. Chen; J.-D. Jia; J.-F. Sheng; H. L. Y. Chan; J.-F. Wang; M. K. K. Li; M. Jiang; M. Popescu; J. J. Y. Sung

Book ID: 108606369
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 178 KB
Volume: 34
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2011.04750.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HBeAg-Negative Chronic Hepatitis B: Cost

HBeAg-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan

✍ David L. Veenstra; Sean D. Sullivan; Ming-Yang Lai; Chuan-Mo Lee; Chia-Ming Tsai 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Cost-effectiveness of peginterferon alfa

Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan

✍ Sean D Sullivan; David L Veenstra; Pei-Jer Chen; Ting-Tsung Chang; Wan-Long Chua 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Efficacy of lamivudine re-treatment for

Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B

✍ J. W. Shin; N. H. Park; J. H. Park; J. H. Park; I. D. Jeong; S-J. Bang; K. R. Jo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Durability of peginterferon alfa-2b trea

Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

✍ Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Kenneth Kar-Lung Yan; Angel Mei-Ling 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 2 views

A viral kinetic study using pegylated in

A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

✍ Vassiliki-Anastasia Sypsa; Konstantinos Mimidis; Nicholas C. Tassopoulos; Dimitr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

We studied viral dynamic parameters in 44 chronic hepatitis B/hepatitis B e antigen (HBeAg)(؊) patients treated with pegylated interferon alfa-2b (PEG-IFN) 100 or 200 g weekly or lamivudine 100 mg daily or the combination of PEG-IFN 100 or 200 g with lamivudine. Patients receiving PEG-IFN monotherap

Comparison of interferon and lamivudine

Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract The aim of this study was to elucidate the long‐term outcome after interferon (IFN) or lamivudine (LMV) treatment in Japanese patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis B. Inclusion criteria were biopsy proven chronic hepatitis or liver cirrhosis, no history